製药无菌填充与包装市场：现况分析与预测（2023-2030）

Pharmaceutical Sterile Fill-Finish Market: Current Analysis and Forecast (2023-2030)

出版日期: 2024年03月01日 | 出版商:

UnivDatos Market Insights Pvt Ltd | 英文 123 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录

无菌填充和精加工製程在製药业中发挥最重要的作用，特别是在註射剂、疫苗和各种其他无菌药品的生产中。这个复杂的过程涉及多个关键步骤，旨在确保最终产品不受微生物污染并确保稳定性和治疗功效。无菌填充和精加工製程在药品製造中至关重要，特别是在註射剂、疫苗和生物製剂的製造中，保持无菌至关重要。这个过程涉及一系列步骤，例如填充、加塞、加盖，有时还需要冷冻干燥，以生产最终剂型。市场驱动因素之一是慢性病的增加和生物製品的发展。例如，疾病管制与预防中心的数据显示，60% 的美国人患有至少一种慢性疾病，例如心臟病、糖尿病或癌症。

2022 年，製药无菌填充和加工市场估值为 35 亿美元，预计 2023 年至 2030 年复合年增长率约为 5%。

产品分为西林瓶、预充式註射器、药筒等。近年来，小瓶领域的需求不断增加。由于西林瓶具有多功能性、与多种药物的兼容性以及更高的安全性，长期以来一直是製药业无菌填充过程的选择。

依应用，市场分为疫苗、生物製剂、生物相似药等。其中，生物相似药类别预计将以最高的复合年增长率成长。由于对创新治疗的需求不断增加以及一些重磅生物製剂的专利到期，生物相似药正在经历显着增长。

为了更瞭解产业市场采用情况，市场包括北美（美国、加拿大、北美其他地区）、欧洲（德国、英国、法国、义大利、西班牙、欧洲其他地区）、亚太地区（中国、日本）、印度、韩国、澳洲和亚太地区其他地区）以及世界其他地区。到 2022 年，北美将在製药无菌填充和加工市场中占压倒性占有率。北美拥有完善的医疗基础设施，不断上涨的医疗成本和不断增加的慢性病患者数量是推动北美市场成长的主要因素。

市场上营运的主要公司包括 Baxter Biopharma Solutions Boehringer Ingelheim、Vetter Pharma、Fresenius Kabi、Pfizer CenterOne、Aenova、Wuxi Biologics、Jubilant Hollister，其中包括 Steer、Bushu Pharmaceutical 和 LSNE Contract Manufacturing。

北美製药无菌填充与加工市场
- 美国
- 加拿大
- 其他北美地区
欧洲製药无菌填充加工市场
- 德国
- 英国
- 法国
- 义大利
- 西班牙
- 其他欧洲地区
亚太製药无菌填充与加工市场
- 中国
- 日本
- 印度
- 亚太地区其他国家
其他地区药品无菌填充加工市场

第10章製药无菌填充与整理市场动态

市场驱动因素
市场课题
影响分析

第 11 章製药无菌填充与精加工市场机会

第 12 章药品无菌填充与加工市场趋势

第十三章供需分析

需求方分析
供给面分析

第14章价值链分析

第15章比赛场景

竞争状况
- 波特五力分析

第十六章公司简介

Baxter BioPharma Solutions
Boehringer Ingelheim
Vetter Pharma
Fresenius Kabi
Pfizer CentreOne
Aenova
WuXi Biologics
Jubilant HollisterStier
Bushu Pharmaceuticals
LSNE Contract Manufacturing

第十七章免责声明

简介目录

Product Code: UMHE212670

The sterile fill-finish procedure holds paramount importance within the pharmaceutical sector, particularly concerning the manufacturing of injectable medications, vaccines, and various other sterile pharmaceuticals. This intricate process encompasses multiple pivotal stages aimed at guaranteeing the absence of microbial contamination in the final product, while also safeguarding its stability and therapeutic effectiveness. The sterile fill-finish process is a critical step in pharmaceutical manufacturing, especially for injectable drugs, vaccines, and biologics where maintaining sterility is paramount. It involves a series of steps including filling, stoppering, capping, and sometimes lyophilization (freeze-drying) to produce the final dosage form. One of the major driver for the growth of the market is associated with the increasing prevalence of chronic diseases and the development of biologic drugs. For instance, as per the data of Certers for Disease Control and Prevention, 60% of the Amaercans are living with atleast one of the chronic disorder like heart disease, diabetes, or cancer.

The Pharmaceutical Sterile Fill-Finish Market was valued at USD 3,500 Million in 2022 and is expected to grow at a CAGR of around 5% from 2023-2030.

Based on the product, the market is segmented into Vials, Prefilled Syringes, Cartridges, and Others. Vials segment have been experiencing an increasing demand in recent years. Vials have long been a preferred choice in the pharmaceutical industry for sterile fill-finish processes due to their versatility, compatibility with a wide range of drugs, and enhanced safety features.

On the basis of application, the market is categorized into Vaccine, Biologics, Biosimilars, and Others. Among these, the Biosimilar category is expected to grow with the highest CAGR. Biosimilars were experiencing significant growth due to increased demand for innovative therapies and the expiration of patents on several blockbuster biologic drugs.

For a better understanding of the market adoption of the industry, the market is analyzed based on its worldwide presence in countries such as North America (U.S., Canada, and the Rest of North America), Europe (Germany, UK, France, Italy, Spain, Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, Australia, and Rest of Asia-Pacific), Rest of World. North America held dominating share of Pharmaceutical Sterile Fill-Finish Market in 2022. The presence of well-established healthcare infrastructure, along with the increasing healthcare expenditure and rising cases of chronic disorders in the countries is the major attributing factor for the market growth in North America.

Some of the major players operating in the market include Baxter BioPharma Solutions Boehringer Ingelheim, Vetter Pharma, Fresenius Kabi, Pfizer CentreOne, Aenova, WuXi Biologics, Jubilant HollisterStier, Bushu Pharmaceuticals, LSNE Contract Manufacturing

1.MARKET INTRODUCTION

1.1.Market Definitions
1.2.Main Objective
1.3.Stakeholders
1.4.Limitation

2.RESEARCH METHODOLOGY OR ASSUMPTION

2.1.Research Process of the Pharmaceutical Sterile Fill-Finish Market
2.2.Research Methodology of the Pharmaceutical Sterile Fill-Finish Market
2.3.Respondent Profile

3.MARKET SYNOPSIS

4.EXECUTIVE SUMMARY

5.GLOBAL PHARMACEUTICAL STERILE FILL-FINISH MARKET COVID-19 IMPACT

6.GLOBAL PHARMACEUTICAL STERILE FILL-FINISH MARKET REVENUE, 2020-2030F

7.MARKET INSIGHTS BY PRODUCT

7.1.Vials
7.2.Prefilled Syringes
7.3.Cartridges
7.4.Others

8.MARKET INSIGHTS BY APPLICATION

8.1.Vaccines
8.2.Biologics
8.3.Biosimilars
8.4.Others

9.MARKET INSIGHTS BY REGION

9.1.North America Pharmaceutical Sterile Fill-Finish Market
- 9.1.1.U.S.
- 9.1.2.Canada
- 9.1.3.Rest of North America
9.2.Europe Pharmaceutical Sterile Fill-Finish Market
- 9.2.1.Germany
- 9.2.2.UK
- 9.2.3.France
- 9.2.4.Italy
- 9.2.5.Spain
- 9.2.6.Rest of Europe
9.3.Asia-Pacific Pharmaceutical Sterile Fill-Finish Market
- 9.3.1.China
- 9.3.2.Japan
- 9.3.3.India
- 9.3.4.Rest of APAC
9.4.Rest of the World Pharmaceutical Sterile Fill-Finish Market